Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2005 2
2006 2
2007 2
2008 1
2009 2
2010 1
2011 3
2012 3
2014 1
2015 2
2016 2
2017 1
2021 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Macrolide Inspired Macrocycles as Modulators of the IL-17A/IL-17RA Interaction.
Koštrun S, Fajdetić A, Pešić D, Brajša K, Bencetić Mihaljević V, Jelić D, Petrinić Grba A, Elenkov I, Rupčić R, Kapić S, Ozimec Landek I, Butković K, Grgičević A, Žiher D, Čikoš A, Padovan J, Saxty G, Dack K, Bladh H, Skak-Nielsen T, Feldbaek Nielsen S, Lambert M, Stahlhut M. Koštrun S, et al. Among authors: brajsa k. J Med Chem. 2021 Jun 24;64(12):8354-8383. doi: 10.1021/acs.jmedchem.1c00327. Epub 2021 Jun 8. J Med Chem. 2021. PMID: 34100601
Porphyrins as new endogenous anti-inflammatory agents.
Jelić D, Tatić I, Trzun M, Hrvačić B, Brajša K, Verbanac D, Tomašković M, Čulić O, Antolović R, Glojnarić I, Weygand-Đurašević I, Vladimir-Knežević S, Mildner B. Jelić D, et al. Among authors: brajsa k. Eur J Pharmacol. 2012 Sep 15;691(1-3):251-60. doi: 10.1016/j.ejphar.2012.05.049. Epub 2012 Jun 9. Eur J Pharmacol. 2012. PMID: 22687816
N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity.
Bosnar M, Kragol G, Koštrun S, Vujasinović I, Bošnjak B, Bencetić Mihaljević V, Marušić Ištuk Z, Kapić S, Hrvačić B, Brajša K, Tavčar B, Jelić D, Glojnarić I, Verbanac D, Culić O, Padovan J, Alihodžić S, Eraković Haber V, Spaventi R. Bosnar M, et al. Among authors: brajsa k. J Med Chem. 2012 Jul 12;55(13):6111-23. doi: 10.1021/jm300356u. Epub 2012 Jun 25. J Med Chem. 2012. PMID: 22697905
Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects.
Culić O, Eraković V, Cepelak I, Barisić K, Brajsa K, Ferencić Z, Galović R, Glojnarić I, Manojlović Z, Munić V, Novak-Mircetić R, Pavicić-Beljak V, Sucić M, Veljaca M, Zanić-Grubisić T, Parnham MJ. Culić O, et al. Among authors: brajsa k. Eur J Pharmacol. 2002 Aug 30;450(3):277-289. doi: 10.1016/s0014-2999(02)02042-3. Eur J Pharmacol. 2002. PMID: 12208321 Clinical Trial.
Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment.
Parnham MJ, Culić O, Eraković V, Munić V, Popović-Grle S, Barisić K, Bosnar M, Brajsa K, Cepelak I, Cuzić S, Glojnarić I, Manojlović Z, Novak-Mircetić R, Oresković K, Pavicić-Beljak V, Radosević S, Sucić M. Parnham MJ, et al. Among authors: brajsa k. Eur J Pharmacol. 2005 Jul 4;517(1-2):132-43. doi: 10.1016/j.ejphar.2005.05.023. Eur J Pharmacol. 2005. PMID: 15964564 Clinical Trial.
22 results